Cha Hospital Bundang

Bundang CHA Hospital is a trusted partner affiliated with our company, renowned as a leading comprehensive hospital excelling in cancer treatment, stem cell therapy, and severe disease care. This description highlights the hospital's distinguished history and specialized strengths to build confidence and appeal among international patients. Hospital History Bundang CHA Hospital opened in 1995 as the first comprehensive hospital in a new city development, starting with 500 beds and expanding to 881 beds today. Over 30 years, it has grown from a regional facility into a national leader through dedicated efforts in treatment, research, and education under CHA Medical Group's legacy. In 2025, it celebrated its 30th anniversary, honoring long-term staff and recognizing milestones like pioneering multidisciplinary cancer care. Key Strengths and Features It excels in multidisciplinary cancer treatment, achieving 5,000 cases in the shortest time domestically, starting with pancreaticobiliary cancer and expanding to all types. The hospital leads in stem cell therapies, including umbilical cord blood for cerebral palsy and fetal midbrain-derived cells for rare diseases like Stargardt syndrome, earning research hospital designation in 2013. Specialized centers support global clinical trials with partners like Parexel, alongside collaborations with CHA University and biotech affiliates for innovative drug development. International Patient Services As part of CHA's global network spanning 7 countries and 96 facilities, Bundang CHA offers seamless care for international patients with multilingual support and concierge services. Its advanced infrastructure, including adjacent women's and rehabilitation centers, ensures integrated treatment. The hospital's reputation for cutting-edge therapies attracts patients worldwide, providing VIP coordination for comfortable, high-quality experiences.